Avaleht/Aktsiad/NVRO

NVRO

USD

Nevro Corp. Common Stock

$5.840+0.000 (0.000%)

Reaalajas hind

Healthcare

Meditsiiniseadmed

Ameerika Ühendriigid

Hinnagraafik

Graafiku andmed pole saadaval

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$5.840

Kõrge

$5.860

Madal

$5.840

Maht

N/A

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

224.1M

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

1.35M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $3.165Praegune $5.840Kõrge $13.3

Seotud uudised

24. veebr 2025 · 17:03

PR Newswire

Shareholder Alert: The Ademi Firm investigates whether Nevro Corp. is obtaining a Fair Price for its Public Shareholders

The Ademi Firm is investigating Nevro (NYSE: NVRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus ...

Vaata rohkem

Shareholder Alert: The Ademi Firm investigates whether Nevro Corp. is obtaining a Fair Price for its Public Shareholders

7. veebr 2025 · 18:58

Analyst Upgrades

Canaccord Genuity Maintains Hold on Nevro, Raises Price Target to $5.85

Canaccord Genuity analyst William Plovanic maintains Nevro with a Hold and raises the price target from $4 to $5.85.

Vaata rohkem

Canaccord Genuity Maintains Hold on Nevro, Raises Price Target to $5.85

7. veebr 2025 · 14:23

Analyst Upgrades

Piper Sandler Upgrades Nevro to Neutral, Lowers Price Target to $5.85

Piper Sandler analyst Adam Maeder upgrades Nevro from Underweight to Neutral and lowers the price target from $6 to $5.85.

Vaata rohkem

Piper Sandler Upgrades Nevro to Neutral, Lowers Price Target to $5.85

6. veebr 2025 · 14:30

GlobeNewswire

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE:GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE:NVRO), a global medical device company that is

Vaata rohkem